Nixon Peabody
Pac Premier
You are here:  Home  >  Biotech  >  Current Article

Sientra stock climbs despite reporting higher net losses

By   /   Thursday, August 8th, 2019  /   Comments Off on Sientra stock climbs despite reporting higher net losses

    Print       Email
Goleta-based breast implant maker Sientra topped $20 million in sales for its second quarter, the company announced Aug. 8, sending shares up more than 13 percent after the market closed. Net losses ballooned 126 percent to $40.8 million, or $1.19 per share, nearly double average analyst estimates of 67 cents per share. The increase came…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Henry Dubroff

Dubroff: After a decade ruled by tech, value stocks could make a comeback

Read More →